Aspen Neuroscience, Inc. (ASPE)

NASDAQ: ASPE · Real-Time Price · USD

11.58

-1.19 (-9.29%)

At close: Nov 5, 2026, 4:00 PM EST

11.99

+0.42 (3.59%)

After-hours: Nov 5, 2026, 4:15 PM EST

Aspen Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	17.16	17.47	17.87
Research & Development	49.48	41.83	35.59
Operating Expenses	66.64	59.31	53.46
Operating Income	-66.64	-59.31	-53.46
Interest & Investment Income	2.61	1.79	4.4
Other Non Operating Income (Expenses)	-2.81	-4.54	0.5
Pretax Income	-66.84	-62.06	-48.56
Net Income	-66.84	-62.06	-48.56
Net Income to Common	-66.84	-62.06	-48.56
Net Income Growth	-	-	-
Shares Outstanding (Basic)	11	10	9
Shares Outstanding (Diluted)	11	10	9
Shares Change	-	11.41%	-
EPS (Basic)	-6.29	-6.01	-5.24
EPS (Diluted)	-6.29	-6.01	-5.24
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-66.51	-62.54	-46.75
Free Cash Flow Per Share	-6.26	-6.06	-5.05
EBITDA	-64.92	-57.67	-52.1
D&A For EBITDA	1.71	1.64	1.36
EBIT	-66.64	-59.31	-53.46

SEC Filings: 10-K · 10-Q